# FDA 483 - Mericon Industries Inc. - February 14, 2025

Source: https://www.keypedia.com/records/483/mericon-industries-inc/2f395cf8-0d47-479b-88e1-3daa1965fd18

> FDA 483 for Mericon Industries Inc. on February 14, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mericon Industries Inc.
- Inspection Date: 2025-02-14
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: Mericon Industries Inc. in Peoria, IL, received a Form 483 for significant deficiencies in their drug manufacturing operations. The inspection revealed critical issues including inadequate raw material testing, lack of proper quality control unit procedures, absence of final product testing for active ingredients, and incomplete batch production records. These findings indicate a systemic failure to ensure drug product quality, purity, and strength.

## Related Documents

- [WARNING_LETTER - 2024-08-21](https://www.keypedia.com/records/warning_letter/mericon-industries-inc/56d455e4-cc7f-43f6-9e8a-ba685ab62f69)

## Related Officers

- [Matthew M. Schuckmann](https://www.keypedia.com/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)

Company: https://www.keypedia.com/companies/mericon-industries-inc/60eec6e7-15fb-41e5-8c73-e726abd68ffd

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669